08189 TEDA BIOMEDICAL
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 0.84X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | 106.9% | Net Margin | N/A |
Total Debt/Equity | 722.0% | Return on Equity | N/A |
Price/Book | 37.10X | Return on Assets | N/A |
(HKD 0.460) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | -29.57 | -22.22 | -30.78 | -51.68 | -56.96 |
---|---|---|---|---|---|
Net Profit Growth (%) | -33.1 | +27.8 | +40.5 | +9.3 | +39.8 |
Earnings Per Share (HKD) | -0.016 | -0.012 | -0.016 | -0.027 | -0.03 |
Earnings Per Share Growth (%) | -33.3 | +27.8 | +40.7 | +9.3 | +39.7 |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
P/E* (X) | N/A | N/A | N/A | N/A | N/A |
Yield (%) | N/A | N/A | N/A | N/A | N/A |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | 0.012 | 0.029 | 0.042 | 0.065 | 0.090 |
Auditors' Opinion | Unqualified | Unqualified # | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
(RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
Cover Period (mths) | 6 | 6 | NA | 6 |
---|---|---|---|---|
Turnover | 226.407 | 211.568 | +7.0 | 185.916 |
Operating Result | -8.43 | -5.525 | +52.6 | -14.139 |
Profit Before Taxation | -8.43 | -5.525 | +52.6 | -14.139 |
Taxation | 0 | 0 | N/A | -0.041 |
Profit /( Loss) After Taxation | -8.43 | -5.525 | +52.6 | -14.098 |
Minority Interests | -2.003 | -1.402 | +42.9 | -2.848 |
Net Profit | -6.426 | -4.123 | +55.9 | -11.25 |
Earnings Per Share () | -0.0035 | -0.0023 | +52.2 | -0.0064 |
Announcement Date | 2025-08-29 | 2024-08-30 | NA | 2023-08-10 |
* Annualised
Last Update Time: 2025-09-08 21:40:25